Surmodics, Inc. (SRDX)
NASDAQ: SRDX · IEX Real-Time Price · USD
26.17
0.00 (0.00%)
Apr 26, 2024, 4:00 PM EDT - Market closed
Surmodics Revenue
Surmodics had revenue of $138.20M in the twelve months ending December 31, 2023, with 35.65% growth year-over-year. Revenue in the quarter ending December 31, 2023 was $30.55M with 22.54% year-over-year growth. In the fiscal year ending September 30, 2023, Surmodics had annual revenue of $132.58M with 32.65% growth.
Revenue (ttm)
$138.20M
Revenue Growth
+35.65%
P/S Ratio
2.70
Revenue / Employee
$367,561
Employees
376
Market Cap
372.56M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Sep 30, 2023 | 132.58M | 32.63M | 32.65% |
Sep 30, 2022 | 99.95M | -5.19M | -4.93% |
Sep 30, 2021 | 105.14M | 10.27M | 10.83% |
Sep 30, 2020 | 94.86M | -5.21M | -5.21% |
Sep 30, 2019 | 100.08M | 18.74M | 23.04% |
Sep 30, 2018 | 81.34M | 8.22M | 11.25% |
Sep 30, 2017 | 73.11M | 1.75M | 2.45% |
Sep 30, 2016 | 71.37M | 9.47M | 15.30% |
Sep 30, 2015 | 61.90M | 4.46M | 7.76% |
Sep 30, 2014 | 57.44M | 1.31M | 2.33% |
Sep 30, 2013 | 56.13M | 4.20M | 8.10% |
Sep 30, 2012 | 51.93M | -828.00K | -1.57% |
Sep 30, 2011 | 52.76M | -1.73M | -3.18% |
Sep 30, 2010 | 54.49M | -67.05M | -55.17% |
Sep 30, 2009 | 121.53M | 24.48M | 25.23% |
Sep 30, 2008 | 97.05M | 23.89M | 32.65% |
Sep 30, 2007 | 73.16M | 3.28M | 4.69% |
Sep 30, 2006 | 69.88M | 7.50M | 12.03% |
Sep 30, 2005 | 62.38M | 12.64M | 25.42% |
Sep 30, 2004 | 49.74M | 6.51M | 15.05% |
Sep 30, 2003 | 43.23M | 13.74M | 46.61% |
Sep 30, 2002 | 29.49M | 6.80M | 29.94% |
Sep 30, 2001 | 22.69M | 4.41M | 24.15% |
Sep 30, 2000 | 18.28M | 4.79M | 35.46% |
Sep 30, 1999 | 13.49M | 3.72M | 37.99% |
Sep 30, 1998 | 9.78M | 2.20M | 28.98% |
Sep 30, 1997 | 7.58M | 1.40M | 22.63% |
Sep 30, 1996 | 6.18M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
MultiPlan | 961.52M |
DocGo | 624.29M |
Zynex | 184.32M |
Adaptive Biotechnologies | 170.28M |
Anika Therapeutics | 166.66M |
Harrow Health | 130.19M |
Heron Therapeutics | 127.04M |
Aquestive Therapeutics | 50.58M |
SRDX News
- 9 days ago - Surmodics to Report Second Quarter of Fiscal 2024 Financial Results on May 1 - Business Wire
- 2 months ago - Surmodics to Participate in Upcoming Investor Conferences in March and April - Business Wire
- 3 months ago - Surmodics Reports First Quarter of Fiscal Year 2024 Financial Results; Updates Fiscal Year 2024 Financial Guidance - Business Wire
- 3 months ago - Surmodics Announces Successful Early Clinical Use of Pounce™ LP (Low Profile) Thrombectomy System, Designed to Address a Critical, Unmet Need by Facilitating Removal of Thrombi and Emboli Below the Knee - Business Wire
- 3 months ago - Surmodics to Host Virtual Annual Meeting of Shareholders - Business Wire
- 3 months ago - Surmodics to Report First Quarter of Fiscal 2024 Financial Results on February 1 - Business Wire
- 5 months ago - Surmodics Announces TRANSCEND Trial 36-Month Data Presented at 50th Annual VEITH Symposium - Business Wire
- 5 months ago - Surmodics Announces 24-Month Data from the SWING Trial Presented at VEITHsymposium - Business Wire